Alpha Teknova (NasdaqGM:TKNO) Q4 2025 Earnings call February 26, 2026 05:30 PM ET Company ParticipantsJacob Krahenbuhl - Equity Research AssociateJennifer Henry - SVP of MarketingMatt Lowell - CFOStephen Gunstream - President and CEOConference Call ParticipantsBrendan Smith - Director and Senior Equity Research AnalystMatt Hewett - Senior Research AnalystMatthew Parisi - Equity Research AnalystOperatorGood day, and welcome to Teknova's fourth quarter and full year 2025 financial results call. At this time, ...

eHealth (NasdaqGS:EHTH) Q4 2025 Earnings call February 25, 2026 05:00 PM ET Speaker6Good afternoon, everyone, welcome to eHealth, Inc. conference call to discuss the company's fourth quarter and fiscal year 2025 financial results. At this time, all participants have been placed in listen-only mode. The floor will be open.Good afternoon, and thank you all for joining us. On the call today, Derrick Duke, eHealth's Chief Executive Officer, and John Dolan, Chief Financial Officer, will discuss our fourth quarte ...

Financial Performance - For the full year 2025, Globus Medical reported revenue of $2.939 billion, representing a growth of 16.7% year-over-year, and non-GAAP earnings per share (EPS) of $3.98, up 30.8% [4][22] - In Q4 2025, revenue reached $826.4 million, a 25.7% increase compared to Q4 2024, with non-GAAP EPS of $1.28, growing 52.1% year-over-year [5][23] - The base business revenue for Q4 was $726.7 million, reflecting a 10.6% growth compared to the same quarter last year [5][25] - Adjusted EBITDA margin for Q4 was 35.7%, while the full year margin was 33.4% [6][24] Business Line Performance - The U.S. spine business grew by 10% in Q4 compared to the prior year quarter, continuing a trend of above-market growth [6][27] - Enabling Technologies revenue was $55.6 million in Q4, growing 18.5% year-over-year, driven by increased sales of EGPS systems [11][26] - The trauma business experienced approximately 27% growth in Q4, supported by the legacy trauma line and precise limb lengthening products [15][16] Market Performance - U.S. revenue in Q4 was $665.3 million, growing 27.5% year-over-year, while international revenue was $161.1 million, reflecting a 19% increase [26][27] - The international spine business faced supply chain challenges earlier in the year but showed improvement, culminating in record sales in Q4 2025 [28][80] Company Strategy and Industry Competition - The company aims to penetrate and launch new programs while fostering utilization and service excellence across its install base [14] - Globus Medical is focused on expanding its core spine business while also growing adjacent markets through innovation and product development [18][19] - The company views competition in the enabling technology space as evolving but believes its ExcelsiusGPS system remains a strong offering [12][69] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in the sustainability of U.S. spine growth, citing product launches and a robust sales force as key drivers [68] - The company anticipates continued margin expansion and has set a long-term goal for mid-seventies adjusted gross profit percentage [30][43] - Management acknowledged the challenges faced in international markets but remains optimistic about returning to double-digit growth rates [80] Other Important Information - The company repurchased approximately 4.3 million shares during 2025, with a remaining authorization of $390 million under its share repurchase program [37][38] - Research and development expenses for Q4 were $36.2 million, or 4.4% of sales, reflecting a decrease from the prior year [30][32] Q&A Session Summary Question: Can you bridge the growth expectations for the base business into 2026? - Management noted that 2025 was a tale of two halves, with significant growth in the latter half driven by product launches and sales force expansion [47][48] Question: How do you view market share and the strength of the spine market? - Management believes the U.S. spine business is growing above market and views the overall spine market as relatively healthy [54] Question: What changed in the enabling technology environment? - Management indicated that enabling technology performance was lumpy throughout the year, with a strong Q4 driven by closing delayed pipeline deals [59][60] Question: How sustainable is the U.S. spine growth? - Management sees the growth as durable, supported by ongoing product launches and competitive rep conversions [68][69] Question: What are the headwinds in the international market? - Management highlighted that the international business can grow 12%-15% long-term, with a focus on deepening existing markets rather than expanding into new ones [80]

Core Viewpoint - The webcast presentation for National Healthcare Properties, Inc. focuses on the Fourth Quarter and Full Year 2025 results, highlighting forward-looking statements and financial measures [1][2][3]. Group 1: Forward-Looking Statements - The company will present forward-looking statements that are subject to certain assumptions and risk factors, which may lead to actual results differing from these statements [2]. - These statements are made in accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 [1]. Group 2: Financial Measures - The company will discuss non-GAAP financial measures during the call, which should not be viewed in isolation or as a substitute for GAAP financial results [3]. - A reconciliation of these non-GAAP measures to the most directly comparable GAAP measure will be provided in the fourth quarter 2025 earnings supplemental on the company's website [3]. Group 3: Presentation Logistics - Questions can be submitted during the webcast, and the Investor Relations team will follow up after the presentation [4]. - A copy of the presentation and a replay of the webcast will be available on the company's website later today [4].

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $105.3 million, up 12% year-over-year, and $365.3 million for the full year, growing 16% [37] - Adjusted EBITDA for Q4 grew 5% to $39.2 million, and for the full year, it was $113.6 million, growing 14% with an adjusted EBITDA margin of 31% [41] - Cash flow from operations for the year was $91.8 million, up 28% from the prior year [42] Business Line Data and Key Metrics Changes - Core revenues for Q4 grew 15% to $78.2 million, and for the full year, it grew 16% to $317.9 million due to improved client retention and new business production [37] - Policies in force grew 14% to 1.9 million, accelerating from a 13% growth rate in Q3 2025 [41] - Gross payments per franchise increased by 29% year-over-year, indicating stronger cash flow for franchise owners [13] Market Data and Key Metrics Changes - Total written premiums for Q4 were $1.1 billion, growing 13% year-over-year, and for the full year, it was $4.4 billion, up 17% [40] - Contingent commissions for the full year represented 86 basis points of total written premiums, outperforming expectations [39] Company Strategy and Development Direction - The company aims to accelerate growth within existing agencies, expand corporate sales, and scale enterprise and partnership channels while investing in technology [22] - Goosehead is focused on maintaining a long-term mindset and prioritizing quality over quantity in its franchise network [26] - The company is investing heavily in technology, particularly in AI applications, to enhance efficiency and client experience [17][20] Management's Comments on Operating Environment and Future Outlook - Management believes the insurance market is transitioning from a hard market to a healthier environment, which is beneficial for Goosehead [11] - The company expects low double-digit core revenue growth for the first half of 2026, with acceleration anticipated in the second half as pricing dynamics stabilize [38] - Management is confident in the company's position and the potential for long-term growth driven by technology and strategic partnerships [23] Other Important Information - The company has authorized an additional $180 million for share repurchases, reflecting confidence in its valuation [43] - Goosehead has launched a mobile app and an AI-powered virtual assistant, enhancing client interactions and reducing agent involvement [21] Q&A Session Summary Question: How is the company thinking about home closing transactions and the insurance pricing environment for next year? - Management noted that housing construction has not been a significant headwind and that they are not counting on improvements in housing for guidance in 2026 [47] - Pricing guidance ranges from generally down to moderate increases in homeowners pricing [48] Question: How would regulatory changes like profitability caps impact the business model? - Management expressed uncertainty about the likelihood of such changes but noted that nimble markets may be more durable [50] Question: Why does the company believe agents will not be disintermediated through AI? - Management highlighted the complexity of home insurance and the continued demand for human guidance in the process [55] Question: How is the Digital Agent platform expected to impact customer retention? - Management indicated that existing clients purchasing additional policies through the platform could improve retention by rounding out their total account [60] Question: What is the expected investment spending for 2026? - Management expects total cash investment spending to be between $25 million and $35 million, with a portion impacting the P&L [71] Question: How is the health of the agency community and productivity in the franchise channel? - Management reported strong same-store sales growth of 19% in Q4 and noted that the franchise community is healthier than in the past [75]

Financial Data and Key Metrics Changes - For 2025, net sales increased by 5.4% to $1.552 billion, and adjusted EBITDA increased by 13.9% to $275.3 million compared to 2024 [4][16] - The adjusted gross profit margin for the full year 2025 increased by 60 basis points to 48.7% from 48.1% in 2024 [16] - Free Cash Flow for 2025 totaled $35.1 million, down from $98.1 million in 2024, impacted by $65 million of tariff costs [17] Business Line Data and Key Metrics Changes - Hardware and Protective Solutions (HPS) net sales increased by 7.8% to $1.2 billion, with adjusted EBITDA rising by 26% to $196.3 million [10] - Robotics and Digital Solutions (RDS) net sales increased by 1.6% to $220.2 million, with nearly 3,500 MiniKey 3.5 machines installed [11][12] - Canadian business net sales decreased by 6.6% compared to the prior year, with adjusted EBITDA margins just shy of 10% [12] Market Data and Key Metrics Changes - Existing home sales remained soft at 4.06 million, unchanged from 30-year lows in 2024, impacting home improvement projects [8] - The company does not expect any meaningful changes in the macro environment that could provide tailwinds for growth in 2026 [7] Company Strategy and Development Direction - The company plans to focus on expanding its pro business, diversifying its customer base, and pursuing bolt-on acquisitions [14][13] - The M&A pipeline is healthy, with several exciting opportunities being explored [13] - The company aims to control costs and improve customer service while investing in growth opportunities [24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving solid revenue and earnings gains throughout 2026, despite a challenging market environment [25] - The company anticipates full-year 2026 net sales between $1.6 billion and $1.7 billion, with adjusted EBITDA expected to grow by 1.7% [5][20] - Management highlighted the importance of new business wins and pricing strategies in driving growth [7][19] Other Important Information - The company expects to invest between $70 million and $75 million in capital expenditures in 2026, similar to 2025 [22] - The company plans to continue stock repurchases to offset dilution from employee equity grants [23] Q&A Session Summary Question: Can you walk through the cadence of the gross margins for Q1? - Management indicated that Q1 will likely be the low point for gross margins, with expectations slightly below the 46%-47% range due to high-cost inventory [29][30] Question: What gives you confidence in new business wins for 2026? - Management highlighted several initiatives and a strong sales team, along with participation in industry events to showcase new products [32][34] Question: What is the outlook for the Protective Solutions business? - Management noted near-term dynamics affecting sales but expressed confidence in new product launches and integration of the Intex DIY business [39][40] Question: How should we model expectations for RDS given the customer transition? - Management stated that the customer transition will continue into Q2, but they expect growth in RDS due to successful rollouts of new machines [43][45] Question: What are the long-term targets for organic revenue and EBITDA growth? - Management reaffirmed confidence in long-term targets of 6% and 10% organic growth, with an upcoming Investor Day to discuss these further [56][58] Question: How is the M&A environment compared to last year? - Management expressed optimism about the M&A environment, noting more opportunities are coming to the table and a busy M&A team [73]

Investor Presentation Version 2.17.2026 Contents | . | | --- | | . | | . | | 】【 】 【 】 】 】 】 【 】 】 】 】 【 】 【 】 】 】 】 】 【 】 【 】 【 】 【 】 【 】 【 】 【 】 【 】 【 】 【 】 【 】 】 】 】 】 】 】 】 】 【 】 【 】 】 】 】 】 | | . | | Contacts | | --- | Michael Wherley Vice President, Investor Relations 860-827-3833 michael.wherley@sbdinc.com Christina Francis Senior Director, Investor Relations 860-438-3470 Engineered Fastening Pages 20 – 22 Appendix Pages 23 – 31 christina.francis@sbdinc.com 1000 Stanley Drive New Britain, CT 06053 inv ...

Financial Data and Key Metrics Changes - For the full year 2025, the company reported a 3% local currency revenue growth, a 10% local currency Adjusted EBITDA growth, and a 15% local currency Adjusted EPS growth [5][6] - The overall Adjusted EBITDA margin improved by 100 basis points [5] - In Q4 2025, the company achieved a 2% local currency revenue growth and flat adjusted local currency operating profit [5][6] Business Line Data and Key Metrics Changes - The Color Group delivered 7.4% local currency revenue growth and 16.9% local currency operating profit growth for the year, with an Adjusted EBITDA margin improvement to 23.7% from 22.1% [8][10] - The Flavors and Extracts Group experienced a 1.3% local currency revenue decline but a 3.4% increase in local currency operating profit, with an Adjusted EBITDA margin of 16.7% [10][11] - The Asia Pacific Group reported a 2.4% local currency revenue growth and a 3.8% local currency operating profit growth for the year [12][13] Market Data and Key Metrics Changes - The Color Group's performance is driven by strong natural color conversion momentum in the U.S., Canada, and parts of Latin America [6][7] - The Flavors and Extracts Group faced challenges due to severe weather events impacting agricultural ingredients, leading to a one-time inventory loss of approximately $3 million [11][12] - The Asia Pacific Group is expected to recover from regional demand disruptions, with a bounce back anticipated in the latter half of 2026 [13][14] Company Strategy and Development Direction - The company is focused on capturing substantial opportunities in natural color conversions, which is considered the largest opportunity in its history [7][8] - Investments in research and development, production capacity, and supply chain resilience are emphasized to support customer needs during the conversion process [8][16] - The company plans to invest $150 million-$170 million in capital expenditures for 2026, with a total of $225 million to $250 million allocated for natural color conversion-related capital expenditures from 2025 to 2028 [16][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit growth in the Color Group for 2026, driven by natural color conversion activities [21][75] - The company anticipates a slower start to 2026 for the Flavors and Extracts Group, with expectations of strengthening revenue and profit performance as the year progresses [12][15] - Management noted that the first half of 2026 will see challenges in profit leverage due to ongoing investments, but expects significant growth in the second half [15][16] Other Important Information - The company reported cash flow from operations of $45 million in Q4 2025, up from $21 million in the same quarter of 2024 [25] - The consolidated adjusted tax rate was 17.1% in Q4 2025, compared to 24.9% in Q4 2024 [24] - The company’s net debt to adjusted EBIT ratio was 2.3x as of December 31, 2025 [25] Q&A Session Summary Question: Conversion opportunity and pipeline for 2026 - Management indicated that approximately $5 million in conversion revenue was invoiced in Q3 and Q4 2025, with expectations for acceleration in Q1 and Q2 2026 [33][34] Question: Impact of FDA changes on conversion timing - Management believes that FDA guidance will not materially change the conversion timelines, as customer commitment to conversion is driven by consumer demand [70][72] Question: Expectations for flavors and extracts improvement - Management expressed confidence in mid-single-digit revenue growth for the Flavors and Extracts Group, with a recovery in agricultural ingredients contributing to this growth [84][86]

Q4 and full year 2025 earnings presentation Making Life Better Forward-looking statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to expectations of Ingersoll Rand Inc. (the "Company" or "Ingersoll Rand") regarding the performance of its business, its financial results, its liquidity and capital resources and other non-historical statements. These forward-looking statements generally are ...

Q4 2025 Earnings Report © 2026 Pinterest. All rights reserved. Non-GAAP Financial Measures To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States ("GAAP"), we use the following non-GAAP financial measures: Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP costs and expenses (including non-GAAP cost of revenue, research and development, sales and marketing, and general and administrative) ...